|4Jan 28, 5:34 PM ET

INTERLEUKIN GENETICS INC 4

4 · INTERLEUKIN GENETICS INC · Filed Jan 28, 2016

Insider Transaction Report

Form 4
Period: 2016-01-27
KORNMAN KENNETH S
DirectorChief Scientific Officer/Pres.
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-01-27+400,000400,000 total
    Exercise: $0.05Exp: 2026-01-27Common Stock (400,000 underlying)
Footnotes (2)
  • [F1]The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on 1/27/2016, which was the grant date of the option.
  • [F2]The option vests as to 25% of the shares on January 27, 2017, and 1/36th of the shares on the first day of each month beginning on February 1, 2017.

Documents

1 file
  • 4
    v429922_4.xmlPrimary

    OWNERSHIP DOCUMENT